According to IQVIA™, a leading healthcare data and analytics provider, U.S. annual sales for Abiraterone Tablets, USP, 500 mg, for the 12 months ended November 2020 were approximately $413 million.

CivicaScript,® a nonprofit company dedicated to bringing low-cost generic medicines to U.S. consumers, announced today that it has lowered the price of its lead product, Abiraterone Acetate ...

Johnson & Johnson’s AKEEGA® (niraparib and abiraterone acetate dual-action tablet) is the first PARP inhibitor combo to show improved efficacy in patients with HRR-mutated mHSPC vs. current ...

CivicaScript's first product is hitting the market. The public benefits company and sister to Civica Rx is making its first generic available: 250-mg abiraterone acetate tablets. The drug is used ...

The New Drug Application (NDA) for niraparib in combination with abiraterone acetate, in the form of a dual-action tablet (DAT), plus prednisone, has been submitted to the Food and Drug ...

It comes as a tablet to take by mouth, on an empty stomach. Dosage & When it is to be taken Adult- PO- The recommended dose is 1000mg once daily with prednisone 5mg twice daily.

LEHI, Utah, Feb. 24, 2025 /PRNewswire/ -- CivicaScript,® a nonprofit company dedicated to bringing low-cost generic medicines to U.S. consumers, announced today that it has lowered the price of ...

This orally administered, dual-action tablet (DAT) consists of a combination of niraparib, a highly selective poly (ADP-ribose) polymerase (PARP) inhibitor, and abiraterone acetate, a CYP17 ...

Reduced manufacturing costs mean lower prices for members, patients. LEHI, Utah, Feb. 24, 2025 /PRNewswire/ -- CivicaScript,® a nonprofit company dedicated to bringing low-cost generic medicines to ...

Civicascript® Lowers Price Of Its Generic Abiraterone Tablets. Date. 2025-02-24 09:31:59. Share on Facebook ...